Drug Shortage Report for CASPOFUNGIN FOR INJECTION

Last updated on 2021-11-03 History
Report ID 142494
Drug Identification Number 02486989
Brand name CASPOFUNGIN FOR INJECTION
Common or Proper name Caspofungin for Injection 50 mg Vial 10 mL
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) CASPOFUNGIN
Strength(s) 50MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 mL
ATC code J02AX
ATC description ANTIMYCOTICS FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-07-14
Estimated end date 2021-11-02
Actual end date 2021-11-02
Shortage status Resolved
Updated date 2021-11-03
Company comments
Health Canada comments
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2021-11-03 English Compare
v9 2021-11-02 French Compare
v8 2021-11-02 English Compare
v7 2021-10-27 French Compare
v6 2021-10-27 English Compare
v5 2021-10-01 French Compare
v4 2021-10-01 English Compare
v3 2021-07-15 English Compare
v2 2021-07-14 French Compare
v1 2021-07-14 English Compare